Compound Summary
Compound Information
clotrimazole
Compound Name: | clotrimazole |
Compound CID: | 2812 |
Synonyms: | clotrimazole 23593-75-1 Lotrimin Canesten Mycelex More... |
Iupac Name: | 1-[(2-chlorophenyl)-diphenylmethyl]imidazole |
InChI: | InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H |
InChIKey: | VNFPBHJOKIVQEB-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4 |
Isomeric Smiles: | C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4 |
Molecular Weight: | 344.8 |
Molecular Formula: | C22H17ClN2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
clotrimazole
Molecular Weight: | 344.8 |
Molecular Formula: | C22H17ClN2 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 25 |
Complexity: | 396 |
Synonyms
clotrimazole
| clotrimazole | clotrimazole |
|---|---|
clotrimazole |
23593-75-1 |
Lotrimin |
Canesten |
Mycelex |
Clotrimazol |
Mycosporin |
Empecid |
Mykosporin |
Gyne lotrimin |
Chlotrimazole |
Trimysten |
1-(o-Chlorotrityl)imidazole |
Mycelex G |
Rimazole |
Mycelex 7 |
Tibatin |
Mono-baycuten |
Lotrimin AF Cream |
Mycelex Troches |
Gyne-Lotrimin |
Lotrimin AF Solution |
Mycelex OTC |
Canestine |
Pedisafe |
Veltrim |
Gynix |
Lotrimin Af |
Trivagizole 3 |
Desamix F |
Mycelex-G |
BAY b 5097 |
Fem Care |
Gyne-Lotrimin 3 |
Mycelex-7 |
Clotrimazolum |
Monobaycuten |
(Chlorotrityl)imidazole |
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole |
Canifug |
Lotrimax |
Lotrimin AF Jock-Itch Cream |
Mycelax |
Mycofug |
BAY 5097 |
Mycelex-7 Combination Pack |
Gyne-Lotrimin Combination Pack |
1-(o-Chloro-alpha,alpha-diphenylbenzyl)imidazole |
Gyne-Lotrimin 3 Combination Pack |
Bay-B 5097 |
1-(2-chlorophenyl)-diphenylmethylimidazole |
1H-Imidazole, 1-(2-chlorophenyl)diphenylmethyl- |
FB 5097 |
Lotrimin (TN) |
Mycelex (TN) |
1-(o-Chlorophenyldiphenylmethyl)imidazole |
1-(2-Chlorophenyl)diphenylmethyl-1H-imidazole |
(2-Chlorophenyl)diphenyl-1-imidazolylmethane |
Diphenyl(2-chlorophenyl)(1-imidazolyl)methane |
Diphenyl-(2-chlorophenyl)-1-imidazolylmethane |
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole |
NSC 257473 |
1-(2-chlorophenyl)(diphenyl)methyl-1H-imidazole |
Mycelex: MycosporinRimazole |
Bay b 9057 |
Prestwick_120 |
UNII-G07GZ97H65 |
Bis-phenyl-(2-chlorophenyl)(1-imidazoyl)methane |
Methane, bis-phenyl-(2-chlorophenyl)-1-imidazolyl- |
Bisphenyl-(2-chlorphenyl)-1-imidazolyl-methan |
Lopac-C-6019 |
NSC257473 |
CHEMBL104 |
1H-Imidazole, 1-((2-chlorophenyl)diphenylmethyl)- |
GNF-Pf-3499 |
MLS000028502 |
CHEBI:3764 |
1-(2-chlorophenyl)-diphenyl-methylimidazole |
G07GZ97H65 |
Imidazole, 1-(o-chloro-alpha,alpha-diphenylbenzyl)- |
MFCD00057220 |
NSC-257473 |
NCGC00015251-02 |
Clotrimaderm |
Canestene |
Clomatin |
Cutistad |
Esparol |
SMR000058306 |
Stiemazol |
Nalbix |
FemCare |
Lotrimin Lotion |
Canesten Cream |
CAS-23593-75-1 |
Gino-Lotremine |
Lotrimin Cream |
Mycelex Cream |
Myclo Solution |
Mycelex Solution |
Myclo Cream |
DSSTox_CID_9871 |
Myclo-Gyne |
Pan-Fungex |
Canesten Solution |
Lotrimin Solution |
Neo-Zol Cream |
Bis-phenyl-(2-chlorophenyl)-1-imidazoyl)methane |
DSSTox_RID_78827 |
Mycelex Twin Pack |
DSSTox_GSID_29871 |
CLT |
Lotrimin AF Lotion |
Clotrimazol INN-Spanish |
Clotrimazolum INN-Latin |
1-(o-Chloro-.alpha.,.alpha.-diphenylbenzyl)imidazole |
Myclo Spray Solution |
clotrimeizol |
Jidesheng |
Canesten 1-Day Therapy |
Canesten 3-Day Therapy |
Canesten 6-Day Therapy |
DRG-0072 |
B 5097 |
CCRIS 6245 |
Canesten 1-Day Cream Combi-Pak |
HSDB 3266 |
Canesten Combi-Pak 1-Day Therapy |
Canesten Combi-Pak 3-Day Therapy |
SR-01000075771 |
EINECS 245-764-8 |
BRN 0622318 |
chlortrimazole |
clortrimazole |
Otomax |
1-((o-Chloro-phenyl)diphenylmethyl)imidazole |
Gyne-Lotrimin3 |
Bis-fenil-(2-clorofenil)-1-imidazolil-metano |
Clotrimaderm Cream |
Clotrimazole,(S) |
Bis-fenil-(2-clorofenil)-1-imidazolil-metano Italian |
Bisphenyl-(2-chlorphenyl)-1-imidazolyl-methan German |
clotrimazole crystalline |
Clotrimazole USAN:USP:INN:BAN:JAN |
Spectrum_001343 |
CPD000058306 |
Clotrimazole (Canesten) |
Prestwick0_000267 |
Prestwick1_000267 |
Prestwick2_000267 |
Prestwick3_000267 |
Spectrum2_000128 |
Spectrum3_000359 |
Spectrum4_000295 |
Spectrum5_000781 |
C 6019 |
NCIMech_000609 |
cid_2812 |
SCHEMBL3850 |
1-(2-chlorotrityl)imidazole |
BIDD:PXR0036 |
Lopac0_000315 |
BSPBio_000114 |
BSPBio_002057 |
KBioGR_000850 |
KBioSS_001823 |
5-23-04-00291 (Beilstein Handbook Reference) |
MLS000758243 |
MLS001423972 |
BIDD:GT0450 |
DivK1c_000665 |
SPECTRUM1500200 |
BAY b5097 |
BAYb 5097 |
SPBio_000176 |
SPBio_002333 |
BPBio1_000126 |
GTPL2330 |
component of Otomax (Salt/Mix) |
DTXSID7029871 |
Gyne-Lotrimin3 Combination Pack |
BDBM31774 |
Clotrimazole (JP17/USP/INN) |
HMS502B07 |
KBio1_000665 |
KBio2_001823 |
KBio2_004391 |
KBio2_006959 |
KBio3_001277 |
Imidazole, 1-(o-chloro-.alpha.,.alpha.-diphenylbenzyl)- |
component of Lotrimax (Salt/Mix) |
NINDS_000665 |
HMS1568F16 |
HMS1920O21 |
HMS2051E11 |
HMS2091G10 |
HMS2095F16 |
HMS2235E20 |
HMS3260P12 |
HMS3369I03 |
HMS3393E11 |
HMS3655I09 |
HMS3712F16 |
Pharmakon1600-01500200 |
Imidazole,.alpha.-diphenylbenzyl)- |
BAY-5097 |
BCP02150 |
ZINC3807804 |
Tox21_110111 |
Tox21_300415 |
Tox21_500315 |
CCG-35563 |
NSC756700 |
s1606 |
STK700023 |
SVT-15652 |
AKOS005607024 |
Tox21_110111_1 |
CS-1926 |
DB00257 |
LP00315 |
MCULE-6862012558 |
NC00035 |
NSC-756700 |
SB17418 |
SDCCGSBI-0050303.P005 |
IDI1_000665 |
MRF-0000070 |
QTL1_000024 |
NCGC00015251-01 |
NCGC00015251-03 |
NCGC00015251-04 |
NCGC00015251-05 |
NCGC00015251-06 |
NCGC00015251-07 |
NCGC00015251-08 |
NCGC00015251-09 |
NCGC00015251-10 |
NCGC00015251-11 |
NCGC00015251-13 |
NCGC00015251-14 |
NCGC00015251-27 |
NCGC00093761-01 |
NCGC00093761-02 |
NCGC00093761-03 |
NCGC00093761-04 |
NCGC00093761-05 |
NCGC00093761-06 |
NCGC00254538-01 |
NCGC00261000-01 |
(2-chlorophenyl)diphenylmethylimidazole |
1-(o-chloro-a,a-diphenylbenzyl)imidazole |
AS-13816 |
HY-10882 |
N713 |
1-(2-Chloro-?,?-diphenylbenzyl)imidazole |
SBI-0050303.P004 |
AB0015989 |
Clotrimazole 100 microg/mL in Acetonitrile |
DB-046195 |
1-(2-Chlorophenyl)diphenylmethylimidazole |
455-EP2272972A1 |
455-EP2272973A1 |
455-EP2275420A1 |
455-EP2277872A1 |
455-EP2281816A1 |
455-EP2292595A1 |
455-EP2295055A2 |
455-EP2295416A2 |
455-EP2298748A2 |
455-EP2298764A1 |
455-EP2298765A1 |
455-EP2305642A2 |
455-EP2311453A1 |
455-EP2311808A1 |
455-EP2311829A1 |
AB00051951 |
EU-0100315 |
FT-0603193 |
ST50994242 |
SW196431-5 |
C06922 |
D00282 |
J10369 |
1-(.alpha.-(2-Chlorophenyl)benzhydryl)imidazole |
1-(2-chlorophenyl)-di(phenyl)methylimidazole |
AB00051951-14 |
AB00051951_15 |
AB00051951_16 |
Clotrimazole, VETRANAL(TM), analytical standard |
593C751 |
A816789 |
Q413546 |
1H-Imidazole, 1-(2-chlorophenyl)-diphenylmethyl |
SR-01000075771-1 |
SR-01000075771-6 |
SR-01000075771-8 |
W-107394 |
1-(2-Chloro-phenyl)-diphenyl-methyl-1H-imidazole |
BRD-K15916496-001-14-7 |
SR-01000075771-10 |
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole (9CI) |
3ACDFDF8-38E3-4368-85D0-BDF8AE1E6591 |
Clotrimazole, British Pharmacopoeia (BP) Reference Standard |
Clotrimazole, European Pharmacopoeia (EP) Reference Standard |
Clotrimazole, United States Pharmacopeia (USP) Reference Standard |
Clotrimazole for peak identification, European Pharmacopoeia (EP) Reference Standard |
Clotrimazole, Pharmaceutical Secondary Standard; Certified Reference Material |
117829-71-7 |
Experimental Data
clotrimazole
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -32 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
clotrimazole
Statistics Data
clotrimazole
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -32 | 1 | 1 |
Statistics Data Visualization
clotrimazole
